knowledge -WSS

knowledge

author：entertainment 2025-09-29 22:52:32 - browse：725

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： What PEPFAR has meant on the ground in Ukraine

focus

explore

WSS

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

What to know about Saharan dust affecting the US and how it can affect health

Organ transplantation is at a crossroads. Major reform is needed

After sickle

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Marvel Studios reveals new trailer for 'The Marvels': Watch here

leisure time

knowledge

leisure time

Cancer drug shortages should be causing more outrage

The woman behind the Dana Farber

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pfizer plans to depart BIO

Virginia high school admissions case could be legal follow

Leukemia patients are helped by Syndax's new type of therapy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Patients' immediate access to test results puts radiologists in a bind

In Memoriam: Notable people who died in 2023

What PEPFAR has meant on the ground in Ukraine

entertainment

Caitlin Bernard's story shows physicians can't shy from advocacy

Pfizer plans to depart BIO

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Organ transplantation is at a crossroads. Major reform is needed

Congenital heart disease patients face new threat of heart failure

Pfizer plans to depart BIO

focus

entertainment

explore

focus